Literature DB >> 21665384

Characteristics associated with the diversion of controlled medications among adolescents.

Sean Esteban McCabe1, Brady T West, Christian J Teter, Paula Ross-Durow, Amy Young, Carol J Boyd.   

Abstract

BACKGROUND: The objective of this study was to estimate the lifetime prevalence of diversion (i.e., trading, selling, giving away or loaning) of four classes of controlled medications (pain, stimulant, anti-anxiety, and sleeping) among adolescents, and to identify demographic and behavioral characteristics of adolescents who divert their own controlled medications.
METHODS: A web-based survey was self-administered by 2744 secondary school students from two southeastern Michigan school districts in 2009-2010. The sample consisted of 51% females, 65% Whites, 29% African-Americans, 4% Asians, 1% Hispanics and 1% from other racial categories.
RESULTS: Thirty-three percent of the students had ever been prescribed at least one controlled pain, stimulant, anti-anxiety, or sleeping medication. Approximately 13.8% (n=117) of lifetime prescribed users of controlled medications (n=848) had ever traded, sold, given away or loaned their medications. Multiple logistic regression analyses indicated that being approached to divert medications, nonmedical use of prescription medications, externalizing behaviors, and being non-White were significantly associated with the diversion of controlled medications. Multiple logistic regression analysis indicated that the odds of substance use and abuse for lifetime prescribed users who diverted their controlled medications were significantly greater than prescribed users who never diverted.
CONCLUSIONS: The findings indicate that approximately one in seven prescribed users had diverted their controlled medications in their lifetimes. Being approached to divert medications and substance use are more prevalent among adolescents who diverted their controlled medications. Careful assessments, diligent prescribing and monitoring of controlled medications, and continual patient education could be useful in reducing medication diversion.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21665384      PMCID: PMC3190027          DOI: 10.1016/j.drugalcdep.2011.05.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

1.  Using the drug abuse screening test (DAST-10) to analyze health services utilization and cost for substance users in a community-based setting.

Authors:  M T French; M C Roebuck; K A McGeary; D D Chitwood; C B McCoy
Journal:  Subst Use Misuse       Date:  2001 May-Jun       Impact factor: 2.164

Review 2.  College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.

Authors:  James Zacny; George Bigelow; Peggy Compton; Kathleen Foley; Martin Iguchi; Christine Sannerud
Journal:  Drug Alcohol Depend       Date:  2003-04-01       Impact factor: 4.492

3.  Psychotropic practice patterns for youth: a 10-year perspective.

Authors:  Julie Magno Zito; Daniel J Safer; Susan DosReis; James F Gardner; Laurence Magder; Karen Soeken; Myde Boles; Frances Lynch; Mark A Riddle
Journal:  Arch Pediatr Adolesc Med       Date:  2003-01

4.  Introduction--the validity of self-reported drug use: improving the accuracy of survey estimates.

Authors:  L Harrison; A Hughes
Journal:  NIDA Res Monogr       Date:  1997

5.  Issues of validity and population coverage in student surveys of drug use.

Authors:  L D Johnston; P M O'Malley
Journal:  NIDA Res Monogr       Date:  1985

6.  The drug abuse screening test.

Authors:  H A Skinner
Journal:  Addict Behav       Date:  1982       Impact factor: 3.913

7.  Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness.

Authors:  S A Maisto; M P Carey; K B Carey; C M Gordon; J R Gleason
Journal:  Psychol Assess       Date:  2000-06

8.  Increased methylphenidate usage for attention deficit disorder in the 1990s.

Authors:  D J Safer; J M Zito; E M Fine
Journal:  Pediatrics       Date:  1996-12       Impact factor: 7.124

9.  Sharing prescription medication among teenage girls: potential danger to unplanned/undiagnosed pregnancies.

Authors:  Katherine Lyon Daniel; Margaret A Honein; Cynthia A Moore
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

10.  National trends in the treatment of attention deficit hyperactivity disorder.

Authors:  Mark Olfson; Marc J Gameroff; Steven C Marcus; Peter S Jensen
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

View more
  27 in total

1.  Risk factors associated with benzodiazepine use among people who inject drugs in an urban Canadian setting.

Authors:  Devin Tucker; Kanna Hayashi; M-J Milloy; Seonaid Nolan; Huiru Dong; Thomas Kerr; Evan Wood
Journal:  Addict Behav       Date:  2015-10-09       Impact factor: 3.913

2.  Longitudinal trajectories of non-medical use of prescription medication among middle and high school students.

Authors:  Carol J Boyd; James A Cranford; Sean Esteban McCabe
Journal:  J Addict Dis       Date:  2016-05-11

3.  Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12-34 years in the United States.

Authors:  Li-Tzy Wu; Marvin S Swartz; Kathleen T Brady; Dan G Blazer; Rick H Hoyle
Journal:  J Psychiatr Res       Date:  2014-09-16       Impact factor: 4.791

4.  Age and Cohort Patterns of Medical and Nonmedical Use of Controlled Medication Among Adolescents.

Authors:  Elizabeth Austic; Sean Esteban McCabe; Sarah A Stoddard; Quyen Epstein Ngo; Carol Boyd
Journal:  J Addict Med       Date:  2015 Sep-Oct       Impact factor: 3.702

5.  Friends and relatives as sources of prescription opioids for misuse among young adults: The significance of physician source and race/ethnic differences.

Authors:  Jason A Ford; Corey Pomykacz; Alec Szalewski; Sean Esteban McCabe; Ty S Schepis
Journal:  Subst Abus       Date:  2019-07-11       Impact factor: 3.716

6.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

Review 7.  Prescription medication sharing: a systematic review of the literature.

Authors:  Kebede A Beyene; Janie Sheridan; Trudi Aspden
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

Review 8.  Prescription stimulant medication misuse: Where are we and where do we go from here?

Authors:  Lisa L Weyandt; Danielle R Oster; Marisa E Marraccini; Bergljot Gyda Gudmundsdottir; Bailey A Munro; Emma S Rathkey; Alison McCallum
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

9.  Medical and nonmedical use of prescription stimulants: results from a national multicohort study.

Authors:  Sean Esteban McCabe; Brady T West
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-09-23       Impact factor: 8.829

10.  Diversion of ADHD Stimulants and Victimization Among Adolescents.

Authors:  Quyen M Epstein-Ngo; Sean Esteban McCabe; Philip T Veliz; Sarah A Stoddard; Elizabeth A Austic; Carol J Boyd
Journal:  J Pediatr Psychol       Date:  2015-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.